CVE-2026-6001: ABIS Technology Ltd. Co BAPSİS · Insecure Direct Object Reference
Affects ABIS Technology Ltd. Co BAPSİSSource CVE Database V5
Not known to be exploited · CVSS 8.8 High : upgrade to v.202604152042 soon.
Data as of 30 Oct 2026, 06:59 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 15% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in v.202604152042
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 12 May 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 29 Oct 2026.
What to do
Upgrade ABIS Technology Ltd. Co BAPSİS to v.202604152042.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| ABIS Technology Ltd. Co.BAPSİS | Affected
| Fixed in
|
AI-suggested
If you cannot patch yet, users should exercise caution with user-controlled keys and restrict access where possible. Monitor ABIS Technology Ltd. Co. communications for updates and apply patches promptly once available.
Description
CVE-2026-6001 is a high-severity authorization bypass vulnerability in ABIS Technology Ltd. Co. 's BAPSİS product, affecting versions before 2026-04-15. The flaw involves user-controlled keys that allow exploitation of trusted identifiers, potentially leading to unauthorized access. The vulnerability has a CVSS 3.1 score of 8.8, indicating high impact on confidentiality, integrity, and availability.